https://www.selleckchem.com/products/ncb-0846.html
ICP-OES proved that the overall process efficiency was 47%. Such nanoparticles can be successfully used in the medical industry. Early diagnosis of Prostate cancer (PCa) plays a vital role in successful treatment increasing the survival rate of patients. Prostate Specific Membrane Antigen (PSMA) is over-expressed in almost all types of PCa. The goal of present study is to introduce new 99mTc-labeled peptides as a PSMA inhibitor for specific detection of PCa at early stages. Based on published PSMA-targeting compounds, a set of peptides
Curtir
Comentario
Compartilhar
